Skip to main content
Coloplast logo

Coloplast — Investor Relations & Filings

Ticker · COLO ISIN · DK0060448595 LEI · 529900NN7SOJ5QG82X67 CO Manufacturing
Open in API
Filings indexed 2,462 across all filing types
Latest filing 2024-11-05 Earnings Release
Country DK Denmark
Listing CO COLO

About Coloplast

https://www.coloplast.com

Coloplast is a company that develops, manufactures, and markets medical devices and services for people with intimate healthcare needs. Its principal business areas include Ostomy Care, Continence Care, Interventional Urology, and Wound & Skin Care. By collaborating closely with users, the company creates solutions designed to make life easier for individuals with personal and private medical conditions. Coloplast also provides comprehensive support programs and educational resources for both patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Earnings Release 2024
Earnings Release Classification · 1% confidence The document is titled "Coloplast A/S - Full-Year Financial Results 2023/24" and contains detailed financial performance metrics (organic growth, EBIT margin, revenue, EPS) for the full fiscal year (1 October 2023 - 30 September 2024), along with forward-looking guidance for FY 2024/25. This content strongly indicates a comprehensive annual financial disclosure. Although it mentions a conference call, the core content is the financial summary, which aligns best with an Annual Report (10-K) or a detailed Earnings Release/Interim Report. Since it covers the *full year* and provides extensive detail, it is more comprehensive than a typical Earnings Release (ER). However, it is not explicitly labeled as a 10-K filing. Given the comprehensive nature of the full-year results announcement, it is classified as an Earnings Release (ER) as it is the initial announcement of the full-year results, often preceding or summarizing the formal 10-K filing. The presence of a conference call announcement and the structure suggest an Earnings Release package. FY 2024
2024-11-05 English
Earnings Release 2024
Earnings Release Classification · 1% confidence The document is titled "2023/24 Årsregnskabsmeddelelse" (Annual Financial Statement Announcement) and covers the full fiscal year (1. oktober 2023 – 30. september 2024). It contains detailed financial tables, including the Income Statement, Balance Sheet, Cash Flow, and key performance indicators (KPIs) for the full year and the fourth quarter. The content summarizes the full annual performance, which strongly indicates an Annual Report or a comprehensive report covering the full fiscal year. Since the text provides the full financial results and analysis, it aligns best with the comprehensive nature of an Annual Report (10-K equivalent for non-US filers, or a detailed annual filing). The presence of a CEO quote, forward-looking guidance for the next year, and detailed financial tables confirms this is the main annual financial disclosure, not just a brief release (ER) or a proxy statement (DEF 14A). Although the document is in Danish, the structure and content map directly to a 10-K filing. FY 2024
2024-11-05 Danish
Coloplast A/S - Full-Year Financial Results 2023/24
Earnings Release Classification · 1% confidence The document is titled 'Årsregnskabsmeddelelse 2023/24' (Annual Financial Statement Announcement) for Coloplast A/S. It provides a summary of financial performance, including organic growth, EBIT, and future outlook, and explicitly mentions at the end that the full report is an 'attached file'. According to the 'Menu vs Meal' rule, an announcement that summarizes key highlights and provides a link to the full report is classified as a Report Publication Announcement (RPA). FY 2024
2024-11-05 Danish
Coloplast A/S - Full-Year Financial Results 2023/24
Earnings Release Classification · 1% confidence The document is an 'Announcement of full-year financial results' for Coloplast for the period 1 October 2023 - 30 September 2024. It contains detailed financial highlights, key ratios, sales performance, and strategic updates. While it contains comprehensive financial data, it is structured as an initial earnings release announcement (Announcement no. 06/2024) rather than the full statutory Annual Report (10-K). It provides the key highlights and performance metrics typically found in an Earnings Release. FY 2024
2024-11-05 English
Director's Dealing 2024
Director's Dealing Classification · 1% confidence The document is explicitly titled "Report on transactions of executives and related parties in Coloplast shares and related securities." It details the purchase of shares by a related party to a deputy chairman, citing compliance with the Market Abuse Regulation article 19. This content directly corresponds to the reporting requirements for insider transactions by directors and executives. Therefore, the appropriate classification is Director's Dealing (DIRS).
2024-09-25 English
Director's Dealing 2024
Director's Dealing Classification · 1% confidence The document title is "Indberetning af ledende medarbejderes og disses nærtståendes transaktioner med Coloplast aktier og tilknyttede værdipapirer" (Notification of transactions in Coloplast shares and related securities by senior employees and their closely associated persons). It explicitly references compliance with the Market Abuse Regulation (MAR) Article 19, which mandates disclosure of insider transactions. The content details a 'Køb af aktier' (Purchase of shares) by a person closely associated with a board member (Niels Peter Louis-Hansen, Vice Chairman). This perfectly matches the definition of Director's Dealing (insider trades). Filing Category: Director's Dealing (Code: DIRS).
2024-09-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.